COVID-19: Commonly used steroid reduces the risk of death

COVID-19: Commonly used steroid reduces the risk of death

Image=Wikipedia

[Newsphopick=Gyubin Lee] ]The widely available steroid drug dexamethasone may be key in helping to treat the sickest Covid-19 patients who require ventilation or oxygen, according to researchers in the United Kingdom. Their findings are preliminary, still being compiled and have not been published in a peer-reviewed journal -- but some not involved with the study called the results a breakthrough.

The two lead investigators of the Recovery Trial, a large UK-based trial investigating potential Covid-19 treatments, announced to reporters in a virtual press conference on Tuesday that a low-dose regimen of dexamethasone for 10 days was found to reduce the risk of death by a third among hospitalized patients requiring ventilation in the trial. 

"That's a highly statistically significant result," Martin Landray, deputy chief investigator of the trial and a professor at the University of Oxford, said on Tuesday. "This is a completely compelling result. If one looks at the patients who did not require ventilators but were on oxygen, there was also a significant risk reduction of about one-fifth," Landray said. 

"However, we didn't see any benefit in those patients who were in the hospital, had Covid, but whose lungs were working sufficiently well -- they were not taking either oxygen or on ventilators."

0
0
이 글을 페이스북으로 퍼가기 이 글을 트위터로 퍼가기 이 글을 카카오스토리로 퍼가기 이 글을 밴드로 퍼가기